Skip to main content

Table 3 Inclusion of patient insights into CDR process

From: Patients’ perspectives can be integrated in health technology assessments: an exploratory analysis of CADTH Common Drug Review

Category

Description

Patient insights included in:

Patient summary

CDR protocol

Drug trials

CDEC Recs.

Tier 1: Health status achieved or retained

 Symptom relief

Improvement of specific symptoms, such as fatigue; seizure frequency; attack severity; ability to breathe, to eat, sleep, or move.

25

21

22

17

 Health-related quality of life

General improvement in quality of life, as measured using standard general or disease-specific quality-of-life scales.

18

18

11

13

 Target root cause

Treatment that targets the root cause of the condition, provides a cure, or extends beyond symptom control.

7

7

6

6

 Long life

Increased survival, including slower disease progression, sustained remission, and fewer disease-related deaths.

5

5

3

5

 Tier 1 subtotal

55

51

42

41

Tier 2: Progress of recovery

 Fewer side effects of treatment

Side effects of the treatment anticipated to be fewer, or less severe than current medications.

16

13

5

7

 Ease of adherence

Ability and willingness to continue taking a medication. Can be influenced by number of pills, ability to self-inject, or contraindications while on the medication.

11

7

2

4

 Alternative treatment

Alternatives needed if there is wide variability in individual response to treatment or if treatment efficacy wanes over time.

4

3

3

4

 Fewer treatment supports

Reduction in the need or use of rescue medication or supplementary therapies to relieve symptoms.

3

2

1

0

 Treatment duration

Shorter duration of therapy and/or recovery than current therapies.

3

1

1

1

 Avoid hospitalization

Avoidance of surgery and other procedures requiring hospitalization of the patient.

6

6

3

3

 Cost

Reduction in the cost borne by individual patients in accessing treatment.

6

0

0

3

 Tier 2 subtotal

49

32

15

22

Tier 3: Sustainability of health

 Psychosocial quality of life

Mental, physical, and emotional ability to engage in daily life activities such as work, meeting friends, and caring for children.

7

4

2

1

 Avoid further disease

Prevent disease transmission or subsequent illness, such as infection, infertility, blindness, or related cancers.

6

2

2

3

 Independence

No longer dependent upon a caregiver to receive treatment or for basic self-care.

2

0

0

0

 Tier 3 Subtotal

15

6

4

4

Totals

119

89

61

67

  1. CDEC CADTH Canadian Drug Expert Committee, CDR CADTH Common Drug Review, Rec. Recommendation document